APA (7th ed.) Citation

Yurkiewicz IR, Muffly L, & Liedtke M. (2018). Inotuzumab ozogamicin: A CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Dove Medical Press.

Chicago Style (17th ed.) Citation

Yurkiewicz IR, Muffly L, and Liedtke M. Inotuzumab Ozogamicin: A CD22 MAb–drug Conjugate for Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia. Dove Medical Press, 2018.

MLA (9th ed.) Citation

Yurkiewicz IR, et al. Inotuzumab Ozogamicin: A CD22 MAb–drug Conjugate for Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia. Dove Medical Press, 2018.